These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin. Kovács GL; Liu B; Burbach JP; Van Ree JM; De Wied D Eur J Pharmacol; 1989 Feb; 161(1):27-35. PubMed ID: 2721547 [TBL] [Abstract][Full Text] [Related]
24. Microinjection of anti-vasopressin serum into hippocampus in mice: effects on appetitively reinforced task after intraventricular administration of Arg-vasopressin. Alescio-Lautier B; Metzger D; Devigne C; Soumireu-Mourat B Brain Res; 1989 Oct; 500(1-2):287-94. PubMed ID: 2605497 [TBL] [Abstract][Full Text] [Related]
25. Role of vasopressin in renal vascular changes with hypoxemia and hypercapnic acidosis in conscious dogs. Rose CE; Ragsdale NV; Carey RM Am J Physiol; 1990 Oct; 259(4 Pt 2):R690-702. PubMed ID: 2145777 [TBL] [Abstract][Full Text] [Related]
26. Vasopressin interactions with oxytocin in the control of female sexual behavior. Pedersen CA; Boccia ML Neuroscience; 2006; 139(3):843-51. PubMed ID: 16488546 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles. Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237 [TBL] [Abstract][Full Text] [Related]
29. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor? de Wied D; Elands J; Kovács G Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526 [TBL] [Abstract][Full Text] [Related]
30. Role of septal vasopressin innervation in paternal behavior in prairie voles (Microtus ochrogaster). Wang Z; Ferris CF; De Vries GJ Proc Natl Acad Sci U S A; 1994 Jan; 91(1):400-4. PubMed ID: 8278401 [TBL] [Abstract][Full Text] [Related]
31. The effect of arginine vasopressin and V1 receptor antagonist on brain water in cat. Rosenberg GA; Estrada E; Kyner WT Neurosci Lett; 1988 Dec; 95(1-3):241-5. PubMed ID: 3226612 [TBL] [Abstract][Full Text] [Related]
32. V1 vs. combined V1+V2 vasopressin blockade after hemorrhage in conscious dogs. Liard JF Am J Physiol; 1988 Dec; 255(6 Pt 2):H1325-9. PubMed ID: 2974249 [TBL] [Abstract][Full Text] [Related]
33. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures. Kovács GL; Veldhuis HD; Versteeg DH; De Wied D Brain Res; 1986 Apr; 371(1):17-24. PubMed ID: 3708341 [TBL] [Abstract][Full Text] [Related]
34. Vasopressin dilates the rat carotid artery by stimulating V1 receptors. Rutschmann B; Evequoz D; Aubert JF; Brunner HR; Waeber B J Cardiovasc Pharmacol; 1998 Oct; 32(4):637-41. PubMed ID: 9781933 [TBL] [Abstract][Full Text] [Related]
35. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin. Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985 [TBL] [Abstract][Full Text] [Related]
36. Vasopressin and memory. I. The vasopressin analogue AVP4-9 enhances working memory as well as reference memory in the radial arm maze. Dietrich A; Allen JD Behav Brain Res; 1997 Sep; 87(2):195-200. PubMed ID: 9331487 [TBL] [Abstract][Full Text] [Related]
37. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Hinojosa C; Haywood JR J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211 [TBL] [Abstract][Full Text] [Related]
38. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. García-Villalón AL; Garcia JL; Fernández N; Monge L; Gómez B; Diéguez G Br J Pharmacol; 1996 Aug; 118(7):1848-54. PubMed ID: 8842453 [TBL] [Abstract][Full Text] [Related]
39. Arginine vasopressin enhances sympathetic constriction through the V1 vasopressin receptor in human saphenous vein. Medina P; Acuña A; Martínez-León JB; Otero E; Vila JM; Aldasoro M; Lluch S Circulation; 1998 Mar; 97(9):865-70. PubMed ID: 9580082 [TBL] [Abstract][Full Text] [Related]
40. Prevention of arginine-vasopressin-induced motor disturbances by a potent vasopressor antagonist. Burnard DM; Veale WL; Pittman QJ Brain Res; 1986 Jan; 362(1):40-6. PubMed ID: 2867814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]